Cheaper and Simpler Oral Care for Pneumonia PreventionWashington, D.C. – July 24, 2020 – A new study has found that active ingredients in mouthwash have the potential to prevent bacterial pneumonia. The research is presented at ASM Microbe Online, the annual meeting of the American Society for Microbiology.
Pneumonia affects 450 million people worldwide each year, including 4 million deaths. The study demonstrates that the active ingredients in everyday mouthwashes have an antibacterial effect against pneumonia-causing pathogens, suggesting that regular oral care using mouthwash may lead to simpler and cheaper pneumonia prevention.
The researchers clinically isolated bacteria from sputum, including methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella pneumoniae (K. pneumoniae), Streptococcus pneumoniae (S. pnrumoniae), and Haemophilus influenzae (H. influenzae). These are frequently detected in aspiration pneumonia and nursing- and healthcare- associated pneumonia. The researchers examined whether these bacteria could be killed by exposing them to concentrations of oral antiseptics, like those found in mouthwashes, particularly 0.01% chlorhexidine gluconate (CHG), 0.004% cetylpyridinium chloride (CPC), or 0.1% 1,8-cineole. Considering that gargle time may be different for each individual, they also examined whether the antibacterial effect could be detected after exposure for 10, 20, 30, and 60 seconds, typical durations for gargling.
“Our work suggests that existing CPC-containing mouthwashes should have high antibacterial effects, even at a lower concentration (0.002%),” said Ayami Karita, Health Care Science, Graduate School, Bunkyo Gakuin University, Japan. Although CPC has been reported to have side effects, good number of elderly people whose mucous membranes are fragile should be able to comfortably use it at lower concentrations. CHG’s antibacterial effects depended upon the type of bacteria, but the effects were evident even at concentrations of 0.12% or lower, concentrations previously recommended for the ventilator-associated pneumonia. However, 1,8-cineole was only weakly antibacterial.
“We already know that pneumonia prevention is a global issue and if frequent, advanced oral care can prevent pneumonia, then our method is more feasible than any out there,” said Karita. “This is especially important in geriatrics and elder care, which often lacks resources for more comprehensive pneumonia prevention.”
ASM Microbe Online brings you the dynamic, cutting-edge science of ASM Microbe 2020, the annual meeting of the American Society for Microbiology. Explore the latest research in the microbial sciences with ePosters, hear from experts in the field during live keynotes and access track-related content with a curated selection of on-demand sessions.
ASM is keeping the pulse on the SARS-CoV-2 pandemic with the COVID-19 Research Registry of top-ranked research articles curated by experts. In the eye of a pandemic, this curated database will ensure that scientists, journalists and the public have an efficient way to find the timeliest and most valuable SARS-CoV-2/COVID-19 research from the latest journal articles and preprints.
The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 30,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.
ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.